United Therapeutics (UTHR) -- Legal Victory Boosts Market Confidence | Janus Henderson Global Life Sciences Fund Q3 2026
· gurufocus.com
Share price rose following a favorable court ruling regarding patent infringement.FDA acceptance of a supplemental new drug application for Tyvaso enhances grow
United Therapeutics UTHR was highlighted in the Janus Henderson Global Life Sciences Fund Q3 2026 letter as a contributor to performance, driven by a favorable ...